ORKA — Oruka Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Arca Biopharma Establishes Special Committee Of The Board Of Directors
U.S. STOCKS ON THE MOVE-GameStop Corp, Roblox Corp, Allete Inc
ARCA Biopharma slumps as experimental COVID drug fails to meet study goal
Brief: ARCA Biopharma Reports Topline Results For Aspen-Covid-19 Phase 2B Clinical Trial
Brief: Arca Biopharma Inc Says Believes That Its Current Cash And Cash Equivalents Will Be Sufficient To Fund Its Operations Through Middle Of 2023
Arca Biopharma Up On Completing Patient Enrollment In Covid: 19 study
Brief: Arca Biopharma Announces Completion Of Enrollment In Phase 2B Aspen-Covid-19 Clinical Trial Evaluating Rnapc2 As A Potential Treatment For Patients Hospitalized With Covid-19
Brief: Arca Biopharma Reports Q3 Loss Per Share $0.33
U.S. STOCKS ON THE MOVE-4D Molecular Therapeutics, Amazon.com, Guardforce AI, Apple
U.S. STOCKS ON THE MOVE-Starbucks, Amazon.com, Apple, Guardforce AI
Arca Biopharma Up After Safety Panel Gives Nod To Covid: 19 treatment trial
Brief: ARCA Says COVID-19 Data And Safety Monitoring Committee Recommends Continuing Phase 2B Clinical Trial
Brief: ARCA biopharma Reports Enrollment of First International Patient in Trial Evaluating rNAPc2 as Potential Treatment for COVID-19
Brief: Arca Biopharma Announces Submission Of Percent Patent Application For The Treatment Of Coronavirus Infection And Associated Coagulopathy With Rnapc2
Brief: Arca Biopharma Posts Q2 Loss Per Share Of $0.34
Arca Biopharma Sees Delay In Covid: 19 therapy data, shares fall
Brief: ARCA Biopharma Provides Update On ASPEN-COVID-19 Phase 2B Clinical Trial
Arca Biopharma Up Agreement For Covid: 19 treatment patent rights
Brief: Arca Biopharma Announces Rnapc2 Covid-19 Patent Assignment Agreement